Depression burden and differential treatment effects in PTSD and substance use disorder comorbidity: findings from Project Harmony
European Journal of Psychotraumatology · 31.12.2026 · 17 (1)
DOI: 10.1080/20008066.2026.2747573 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Psychotraumatology, online erschienen am 02.11.2026. Verfasst von Lissette M Saavedra und 10 weiteren Autor:innen. Beteiligte Einrichtung: RTI International, Research Triangle Park, NC, USA. Hauptthemen laut MEDLINE: Stress Disorders, Post-Traumatic, Substance-Related Disorders, Depression. Die Arbeit nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIAAA NIH HHS, NIDA NIH HHS, National Institute on Alcohol Abuse and Alcoholism.
Themen: Sucht und Abhängigkeit, Depression
Abstract (Originalsprache)
Background
Depression commonly co-occurs with posttraumatic stress disorder (PTSD) and substance use disorders (SUDs), yet it remains unclear whether depression meaningfully alters treatment response for individuals with PTSD/SUD. Prior studies have examined depression as an individual predictor with mixed findings but no studies to date have evaluated depression's moderating role across a broad range of PTSD/SUD treatment modalities using harmonised individual patient data (IPD).
Objective
To determine whether baseline depression moderates within- and post-treatment changes in PTSD symptom severity, alcohol use, and drug use across trauma-focused, SUD focused, integrated and pharmacologic interventions in a large PTSD/SUD IPD treatment dataset.
Method
Data were drawn from Project Harmony, an individual patient data meta-analysis of 36 randomised controlled trials. Latent PTSD, alcohol, and drug use severity outcomes were estimated using moderated nonlinear factor analysis. Treatment effects were evaluated longitudinally using multilevel models with propensity score weighting. Depression was examined as both an individual-level and study-level moderator.
Results
Analyses did not detect moderation of individual-level depression across outcomes. In contrast, study-level depression burden significantly moderated selected treatment effects, such that the proportion of participants with depression within each original RCT shaped treatment response. In studies with higher depression burden, trauma-focused psychotherapy produced stronger post-treatment reductions in PTSD symptom severity and alcohol use but smaller in-treatment improvements. Integrated trauma-focused psychotherapy demonstrated comparatively better in-treatment PTSD outcomes. High-depression contexts yielded attenuated PTSD improvements and mixed effects on alcohol use for SUD-focused psychotherapy.
Conclusion
Analyses did not detect evidence that baseline depression, as operationalised within this harmonised dataset, moderated treatment response at the individual level. In contrast, study-level depression burden was associated with differential treatment effects across treatment modalities. These findings suggest that characteristics of treatment populations may influence comparative treatment performance and warrant further investigation in implementation and comparative effectiveness research. Depression did not appear to limit individual PTSD/SUD treatment response.The overall depression burden of a treatment setting shaped how different therapies performed.Findings highlight the importance of considering population context when selecting PTSD and substance use disorder treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- RTI International, Research Triangle Park, NC, USA.
- Department of Psychology, City College of New York, New York, NY, USA.
- Veterans Affairs Center for Clinical Management Research, Health Services Research and Development, Ann Arbor, MI, USA.
- Department of Psychiatry, University of Michigan Medical School Ann Arbor, MI, USA.
- Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC, USA.
- Ralph H. Johnson VA Medical Center, Charleston, SC, USA.
ORCID-Profile: Lissette M Saavedra
Förderung
- NIAAA NIH HHS
- NIDA NIH HHS
- National Institute on Alcohol Abuse and Alcoholism
- National Institute of Drug Abuse
Zitieren
APA
Saavedra, L. M., Blakey, S. M., Lopez-Castro, T., Grau, P. P., Back, S. E., Killeen, T. K., Norman, S. B., Gette, J. A., Ruglass, L. M., Hien, D. A., & Morgan-López, A. A. (2026). Depression burden and differential treatment effects in PTSD and substance use disorder comorbidity: findings from Project Harmony. European Journal of Psychotraumatology, 17(1). https://doi.org/10.1080/20008066.2026.2747573
Vancouver
Saavedra LM, Blakey SM, Lopez-Castro T, Grau PP, Back SE, Killeen TK, et al. Depression burden and differential treatment effects in PTSD and substance use disorder comorbidity: findings from Project Harmony. European Journal of Psychotraumatology. 2026;17(1). doi:10.1080/20008066.2026.2747573
BibTeX
@article{Saavedra2026,
author = {Saavedra, Lissette M and Blakey, Shannon M and Lopez-Castro, Teresa and Grau, Peter P and Back, Sudie E and Killeen, Therese K and Norman, Sonya B and Gette, Jordan A and Ruglass, Lesia M and Hien, Denise A and Morgan-López, Antonio A},
title = {Depression burden and differential treatment effects in PTSD and substance use disorder comorbidity: findings from Project Harmony},
journal = {European Journal of Psychotraumatology},
year = {2026},
volume = {17},
number = {1},
doi = {10.1080/20008066.2026.2747573}
}
EUVIMED